Research2d ago
Cambridge AI Vaccine Passes Human Trials
The University of Cambridge developed the first AI-designed vaccine to successfully pass human clinical trials. This milestone proves that machine learning can accurately predict viral mutations to create effective immunizations. Researchers now have a blueprint for rapid, broad-spectrum protection. This shift reduces vaccine development timelines from years to weeks for future outbreaks.